Latest News
DTx Pharma Promotes Bryan Laffitte, Ph.D. to Chief Scientific Officer
SAN DIEGO, January 11, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the promotion of Bryan Laffitte, Ph.D. to Chief Scientific Officer. “Given [...]
DTx Pharma to Present at the Virtual Biotech Showcase 2021
SAN DIEGO, January 4, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., Chief Executive Officer, will be presenting a [...]
DTx Pharma to Present at Several Upcoming Virtual Events
SAN DIEGO, Nov. 25, 2020 PRNewswire – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., CEO of DTx Pharma, will be [...]
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
PR Newswire, San Diego – November 9, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today the appointment of Denise Bevers as Chief Operating Officer. [...]
DTx Pharma to Present at the Virtual 7th Solebury Trout Fall Private Company Showcase
PR Newswire, San Diego – October 5, 2020 – DDTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., CEO of DTx Pharma, [...]
DTx Pharma to Present at the Chardan Virtual 4th Annual Genetic Medicines Event
PR Newswire, San Diego – September 28, 2020 – DTx Pharma, Inc. (DTx), a privately-held biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease, announced today that Arthur T. Suckow, Ph.D., CEO of DTx Pharma, [...]